Millipore Sigma Vibrant Logo

MABF2262-25UG Anti-Complement receptor 1 Antibody, clone 9H3

MABF2262-25UG
25 μg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      Catalogue NumberMABF2262-25UG
      DescriptionAnti-Complement receptor 1 Antibody, clone 9H3
      Alternate Names
      • C3b/C4b receptor
      • CD35
      Background InformationComplement receptor type 1 (UniProt: P17927; also known as C3b/C4b receptor, CD35, CR1) is encoded by the CR1 (also known as C3BR) gene (Gene ID: 1378) in human. CR1 is a single-pass type I membrane glycoprotein that is expressed in most peripheral blood cells, follicular-dendritic cells, Schwann cells, and glomerular podocytes. It regulates the activation of the complement cascade by serving as a cofactor for the factor I-mediated cleavage of C3b and C4b and also accelerates the decay of the C3 and C5 convertases. It is shown to bind to C3b and C4b opsonized immune complex on erythrocytes and transports them to liver and spleen where they are degraded by phagocytes. CR1 inhibits spontaneous complement activation by impairing the formation and function of the alternative and classical pathway C3/C5 convertases, and by serving as a cofactor for the cleavage by factor I of C3b to iC3b, C3c and C3d,g, and of C4b to C4c and C4d. It also plays a role in immune regulation by contributing to the generation of regulatory T cells from activated helper T cells. CR1 is synthesized with a signal peptide (aa 1-41), which is subsequently cleaved off to generate the mature form with a long extracellular domain (aa 42-1971), a short transmembrane domain (aa 1972-1996) and a cytoplasmic tail (aa 1997-2039). (Ref.: Nickells, M., et al. (1988). Clin. Exp. Immunol. 112(1); 27-33; Reist, CJ et al. (1994). Eur. J. Immunol. 24(9); 2018-2025).
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Applications
      ApplicationAnti-Complement receptor 1, clone 9H3, Cat. No. MABF2262, is a mouse monoclonal antibody that detects complement receptor 1 and has been tested for use in Dot Blot, Flow Cytometry, and Immunocytochemistry.
      Key Applications
      • Dot Blot
      • Flow Cytometry
      • Immunocytochemistry
      Application NotesFlow Cytometry Analysis: A representative lot detected Complement receptor 1 in Flow Cytometry applications (Craig, M.L., et. al. (2005). J Immunol. 174(5):3059-66).

      Dot Blot Analysis: A representative lot detected Complement receptor 1 in Dot Blot applications (Nickells, M., et. al. (1998). Clin Exp Immunol. 112(1):27-33).

      Immunocytochemistry Analysis: A representative lot detected Complement receptor 1 in Immunocytochemistry applications (Craig, M.L., et. al. (2005). J Immunol. 174(5):3059-66).
      Biological Information
      ImmunogenSoluble human complement receptor 1
      Epitopeextracellular domain
      Clone9H3
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityClone 9H3 is a mouse monoclonal antibody that detects human complement receptor type 1. It targets an epitope with in the extracellular domain.
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Species Reactivity NoteHuman. Predicted to react with Non-Human Primates based on 100% sequence homology.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • CR1
      • C3BR
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight223.66 kDa calculated.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Flow Cytometry in TF-1 cells.

      Flow Cytometry Analysis: 1 µg of this antibody detected Complement receptor 1 in one million TF-1 cells.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size25 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MABF2262-25UG 04054839990571

      Documentation

      Anti-Complement receptor 1 Antibody, clone 9H3 FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-Complement receptor 1 Antibody, clone 9H3 Certificats d'analyse

      TitreNuméro de lot
      Anti-Complement receptor 1, clone 9H3 - 3224766 3224766

      Références bibliographiques

      Aperçu de la référence bibliographiqueNº PubMed
      Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
      Craig, ML; Waitumbi, JN; Taylor, RP
      J Immunol  174  3059-66  2004

      Afficher le résumé
      15728520 15728520
      Mapping epitopes for 20 monoclonal antibodies to CR1.
      Nickells, M; Hauhart, R; Krych, M; Subramanian, VB; Geoghegan-Barek, K; Marsh, HC; Atkinson, JP
      Clin Exp Immunol  115  27-36  2001

      Afficher le résumé
      9566786 9566786